1)日本食道学会(編).臨床・病理 食道癌取扱い規約,10版補訂版.金原出版,p39,2008
2)下田忠和.大腸癌研究会プロジェクト研究より─転移・予後因子としてのリンパ管・静脈侵襲程度の再評価 : 判定の精度管理を目指して.武藤徹一郎(監),杉原健一,藤盛孝博,五十嵐正広,他(編).大腸疾患NOW2010,日本メディカルセンター,pp 133-141, 2010
3)Tsukashita S, Kushima R, Bamba M, et al. MUC gene expression and histogenesis of adenocarcinoma of stomach. Int J Cancer 94 : 166-170, 2001
4)Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance : immunohistochemical analysis of 136 lesions. Oncology 61 : 212-220, 2001
5)Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps : alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol 33 : 1016-1022, 2002
6)Shiroshita H, Watanabe H, Ajioka Y, et al. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int 54 : 311-321, 2004
7)遠藤泰志,渡辺英伸,本山悌一,他.胃型・腸型腺癌の特性.胃と腸 38 : 57-65, 2003